![]() |
OncoPet Diagnostics Inc.
Blood test for cancer in dogs |
| Providing Leverage Through Early Cancer Detection | |
|
Cancer markers are molecules produced by cancer cells but almost no by healthy cells. These molecules are released into the blood stream where they can be detected. Some classic cancer markers in humans are PSA for prostate cancer, CEA for colon cancer and CA125 for ovarian cancer. We found a new tumor marker in humans which is produced by most cancer types, regardless of their origin. We called it RECAF. We also found that, unlike other human cancer markers, that dog cancers produce dog RECAF and therefore, we developed a blood test for canine cancer. To the best of our knowledge, this is the first canine cancer test of practical use: The OncoPet RECAF™ cancer test detects approximately 90% of cancers regardless of their type and most importantly, it detects cancer in its early stages, when curability is the highest. It is common knowledge that the earlier the cancer is detected, the better the chances of survival. |
|
|
|
Key points:•About 50% of dogs die of cancer • Early diagnosis is the best weapon against cancer • First cancer test for companion animals • Test detects approximately 90% of cancers • Humans are screened with mammographies or PSA for prostate cancer. How about your dog?
|